Antioxidant Therapy in Inflammatory Bowel Diseases: How Far Have We Come and How Close Are We?
Inflammatory bowel diseases (IBD) pose a growing public health challenge with unclear etiology and limited efficacy of traditional pharmacological treatments. Alternative therapies, particularly antioxidants, have gained scientific interest. This systematic review analyzed studies from MEDLINE, Coch...
Saved in:
| Main Authors: | Lylian Ellen Militão dos Santos Xavier, Thays Cristhyna Guimaraes Reis, Amylly Sanuelly da Paz Martins, Juliana Célia de Farias Santos, Nassib Bezerra Bueno, Marília Oliveira Fonseca Goulart, Fabiana Andréa Moura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/13/11/1369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The medical humanities – How far have we come?
by: Eng Koon Ong, et al.
Published: (2025-04-01) -
Understanding blast-induced neurotrauma: how far have we come?
by: Ibolja Cernak
Published: (2017-06-01) -
Understanding blast-induced neurotrauma: how far have we come?
by: Ibolja Cernak
Published: (2017-11-01) -
Mental health of Syrian refugee adolescents: how far have we come?
by: Sinem Akgül, et al.
Published: (2019-12-01) -
How far have we really come? Civil and political rights in Queensland
by: Harry Hobbs, et al.
Published: (2014-01-01)